Zacks: Analysts Set $79.50 Target Price for Exponent, Inc. (EXPO)

Exponent, Inc. (NASDAQ:EXPO) has earned an average broker rating score of 2.33 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company.

Brokerages have set a 12-month consensus price target of $79.50 for the company and are predicting that the company will post $0.41 earnings per share for the current quarter, according to Zacks. Zacks has also given Exponent an industry rank of 81 out of 265 based on the ratings given to its competitors.

Several equities research analysts have recently issued reports on the company. Zacks Investment Research raised Exponent from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a research note on Thursday, July 20th. Cantor Fitzgerald reissued a “buy” rating and set a $82.00 price target on shares of Exponent in a research note on Sunday, November 5th. ValuEngine raised Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. Finally, SunTrust Banks, Inc. reissued a “hold” rating and set a $77.00 price target on shares of Exponent in a research note on Thursday, October 19th.

WARNING: This story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://ledgergazette.com/2017/11/15/zacks-analysts-set-79-50-target-price-for-exponent-inc-expo.html.

Exponent (NASDAQ:EXPO) traded up $0.50 during trading hours on Thursday, hitting $71.55. The stock had a trading volume of 84,100 shares, compared to its average volume of 101,950. The company has a market cap of $1,833.85, a price-to-earnings ratio of 38.83 and a beta of 0.58. Exponent has a 1-year low of $55.75 and a 1-year high of $77.15.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Wednesday, October 18th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.09. The business had revenue of $87.60 million during the quarter, compared to analyst estimates of $79.69 million. Exponent had a return on equity of 17.21% and a net margin of 16.46%. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period last year, the company earned $0.42 EPS. research analysts anticipate that Exponent will post 2.09 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 22nd. Investors of record on Friday, December 1st will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date of this dividend is Thursday, November 30th. Exponent’s dividend payout ratio is currently 40.98%.

In related news, CEO Paul R. Johnston sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $67.74, for a total transaction of $270,960.00. Following the completion of the sale, the chief executive officer now directly owns 53,240 shares of the company’s stock, valued at approximately $3,606,477.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Paul R. Johnston sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $64.49, for a total value of $322,450.00. Following the sale, the chief executive officer now directly owns 66,335 shares of the company’s stock, valued at $4,277,944.15. The disclosure for this sale can be found here. Insiders have sold a total of 43,993 shares of company stock valued at $3,000,075 over the last three months. 2.80% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC purchased a new position in Exponent during the 2nd quarter worth $278,000. Gotham Asset Management LLC purchased a new position in Exponent during the 1st quarter worth $394,000. UBS Asset Management Americas Inc. increased its holdings in Exponent by 6.9% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 60,030 shares of the business services provider’s stock worth $3,500,000 after purchasing an additional 3,857 shares during the period. Principal Financial Group Inc. increased its holdings in Exponent by 2.3% during the 2nd quarter. Principal Financial Group Inc. now owns 210,098 shares of the business services provider’s stock worth $12,249,000 after purchasing an additional 4,794 shares during the period. Finally, Citadel Advisors LLC increased its holdings in Exponent by 70.1% during the 2nd quarter. Citadel Advisors LLC now owns 10,604 shares of the business services provider’s stock worth $618,000 after purchasing an additional 4,370 shares during the period. Institutional investors own 88.63% of the company’s stock.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply